ABT vs SCNX · P/E 25, rev $44.33B vs rev $400.0K
Abbott Laboratories (ABT) versus Scienture Holdings, Inc. (SCNX) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Scienture Holdings, Inc. (SCNX) is a pharmaceutical retailers company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported SCNX revenue for 2026-06-30 was $400.0K. Net income was -$6.2M. SCNX currently screens at market cap $15.8M.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. SCNX currently screens at market cap $15.8M.
Not investment advice. Open the ABT and SCNX stock pages for the full models.
Not investment advice.